glp 1 receptor agonist agent Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide Agonists: A Scoping Review GLP-1 Receptor Agonists in Neurodegeneration:

Always consult a healthcare professional before starting any treatment

Its benefit to the liver is likely more indirect

Different reconstitution volumes produce different concentrations from the same vial: 50mg vial + 2ml water = 25mg/ml (very concentrated) 50mg vial + 2.5ml water = 20mg/ml (concentrated) 50mg vial + 5ml water = 10mg/ml (standard) 50mg vial + 10ml water = 5mg/ml (dilute) Higher concentrations require smaller injection volumes but may exceed solubility limits for some peptides

One death has been reported from it's use

Some users find they respond well to lower doses and never need to reach the peak phase amounts

MC1R is expressed on keratinocytes, fibroblasts, dendritic cells, mast cells, and other immune cells in the skin , and MT-1-mediated MC1R activation produces anti-inflammatory effects in these cell types through cAMP-mediated suppression of NF-B activation, reduction of pro-inflammatory cytokine production including TNF-alpha and IL-6, inhibition of reactive oxygen species generation, and modulation of dendritic cell maturation and antigen presentation